Massive Transfusion
0
Pipeline Programs
3
Companies
1
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Human BioSciencesWV - Martinsburg
1 programAustralian and New Zealand Massive Transfusion RegistryN/A
CSL SeqirusUK - Maidenhead
1 programAustralian and New Zealand Massive Transfusion RegistryN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
CSL SeqirusAustralian and New Zealand Massive Transfusion Registry
Clinical Trials (1)
Total enrollment: 50,000 patients across 1 trials
Australian and New Zealand Massive Transfusion Registry
Start: Mar 2011Est. completion: Dec 202850,000 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 50,000 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.